SENNA-PLUS
- Product NDC
- 68788-8780
- Requested package NDC
- 68788-8780-3
- 11-digit product format
- 687888780
- Labeler code
- 68788
- Product ID
- 68788-8780_9866db01-d615-4de2-beee-3ffc3775d8fc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides and Docusate Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- 505G(a)(3)
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-12-11
- Substance
- SENNOSIDES; DOCUSATE SODIUM
- Active strength
- 8.6; 50 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SENNA-PLUS
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SENNOSIDES | 8.6 mg/1 |
| DOCUSATE SODIUM | 50 mg/1 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68788-8780-1 | SENNA-PLUS | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 68788-8780-3 | SENNA-PLUS | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 68788-8780-8 | SENNA-PLUS | 120 in 1 BOTTLE | TABLET | 120 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-8780 | SENNA-PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 3 package rows | 20241213_d7146449-c43e-460a-9ae0-aa1966eaa3b6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68788-8780-3 | 68788878003 | 30 TABLET in 1 BOTTLE (68788-8780-3) | 30 tablet | 2024-12-11 | No | No | Current |